Alzheimer’s Association International Conference Jul 26, 2021 at 10:00 AM EDT Supporting Materials Poster - Clinical trial design for a Phase 2a study evaluating the safety, tolerability, pharmacokinetics, and CNS activity of CY6463 in participants with Alzheimer’s disease with vascular pathology 721.7 KB Poster - Peak alpha frequency and N200 latency as predictors of neuropsychological performance in a memory disorders clinic 2.8 MB
Poster - Clinical trial design for a Phase 2a study evaluating the safety, tolerability, pharmacokinetics, and CNS activity of CY6463 in participants with Alzheimer’s disease with vascular pathology 721.7 KB
Poster - Peak alpha frequency and N200 latency as predictors of neuropsychological performance in a memory disorders clinic 2.8 MB